Description

Stryker Takeover Play: The $835M Deal That Could Reshape Its Cardiovascular Future!

Stryker Corporation is moving deeper into the peripheral vascular market through its planned acquisition of Amplitude Vascular Systems for up to $835 million, adding a next-generation hydraulic intravascular lithotripsy platform designed to treat calcified peripheral arterial disease. The deal comes at a notable moment for Stryker, which recently reported a disrupted Q1 2026 due to a cyber incident but maintained full-year guidance, citing healthy procedure volumes, strong capital demand, and confidence in sales recovery through the remainder of the year. Management also described the AVS transaction as a step toward expanding treatment options for peripheral vascular customers and broadening Stryker’s presence in cardiovascular care. The acquisition fits alongside the company’s Inari platform, where Stryker has already entered new call points including vascular surgeons and interventional cardiologists, creating a clearer strategic path for vascular expansion.